Article
Biology
Marion Rosello, Juliette Vougny, Francois Czarny, Marina C. Mione, Jean-Paul Concordet, Shahad Albadri, Filippo Del Bene
Summary: Researchers have successfully generated precise point mutations in zebrafish models using gene editing technology, mimicking oncogenic mutations in human genes and creating new disease models.
Article
Cell Biology
Qianwen Wang, Chenxiang Qi, Pengxiang Min, Yueyuan Wang, Fengwen Ye, Tianxiang Xia, Yujie Zhang, Jun Du
Summary: By regulating MICAL2, the migratory ability of gastric cancer cells can be influenced, and it involves changes in the E-cadherin/beta-catenin signaling pathway.
CELL COMMUNICATION AND SIGNALING
(2022)
Article
Biochemistry & Molecular Biology
Huanhuan Li, Fan Tong, Rui Meng, Ling Peng, Jiaojiao Wang, Ruiguang Zhang, Xiaorong Dong
Summary: In this study, WNT5A protein was found to be significantly downregulated in BM tissues and EGFR-mutant samples of NSCLC patients, with overexpression inhibiting the growth and migration of EGFR-mutant cells. Further research revealed that WNT5A is negatively regulated by E2F1 and that its repression is dependent on the ERK1/2 pathway in EGFR-mutant cells. These findings suggest that targeting the ERK1/2-E2F1-WNT5A pathway could be an effective strategy for treating BM in EGFR-mutant NSCLC.
CELLULAR AND MOLECULAR LIFE SCIENCES
(2021)
Article
Multidisciplinary Sciences
Mirren Charnley, Amr H. Allam, Lucas M. Newton, Patrick O. Humbert, Sarah M. Russell
Summary: A critical stage in T cell development is beta-selection, where the T cell receptor beta (TCR beta) chain is generated and the T cell starts to acquire antigenic specificity. This study identifies E-cadherin as a critical cue within the developing T cell niche that facilitates T cell development. E-cadherin mediates cell-cell interactions and plays a role in the formation of the immunological synapse and alignment of the mitotic spindle during division, ultimately coordinating the beta-selection stage of T cell development.
Article
Biochemistry & Molecular Biology
Mehran Erfani, Mozhdeh Zamani, Seyed Younes Hosseini, Zohreh Mostafavi-Pour, Sayed Mohammad Shafiee, Mohammadreza Saeidnia, Pooneh Mokarram
Summary: Our study reveals a close correlation between E-cadherin levels and ARID1A expression, suggesting that ARID1A downregulation may promote CRC metastasis through decreasing E-cadherin expression and enhancing epithelial cell movement. ARID1A could be a potential therapeutic target for CRC treatment.
MOLECULAR BIOLOGY REPORTS
(2021)
Article
Immunology
Chunyu Dong, Dan Dang, Xuesong Zhao, Yuanyuan Wang, Zhijun Wang, Chuan Zhang
Summary: IL27 is closely associated with the prognosis, immunotherapy response, and tumor microenvironment in melanoma patients, with its high expression inducing immune response and cell death, and being linked to improved patient outcomes.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Oncology
Yijiao Ning, Chaoqun Deng, Chunhong Li, Weiyan Peng, Chun Yan, Jing Ran, Weihong Chen, Yujia Liu, Jiuyi Xia, Lin Ye, Zhengqiang Wei, Tingxiu Xiang
Summary: PCDH20 expression is attenuated in esophageal cancer, possibly due to promoter methylation. PCDH20 exerts anti-tumor effects through MAP3K9 downregulation and inhibition of AKT/β-catenin signaling in ESCC cells.
FRONTIERS IN ONCOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Li Han, Huaiqing Luo, Wenjie Huang, Jiang Zhang, Di Wu, Jinmei Wang, Jiao Pi, Chi Liu, Xiangping Qu, Huijun Liu, Xiaoqun Qin, Yang Xiang
Summary: Persistent injury and improper repair in bronchial epithelial cells contribute to airway inflammation and remodeling in asthma. E-cadherin plays a role in regulating the balance between EMT and MET during injury repair by inhibiting EMT features, enhancing MET features, and decreasing TGF-beta 1 secretion and Snail expression, ultimately facilitating epithelial repair.
Article
Oncology
Jagat S. Chauhan, Michael Hoelzel, Jean-Philippe Lambert, Francesca M. Buffa, Colin R. Goding
Summary: Bidirectional interactions between tumor cells and the microenvironment play a crucial role in tumor evolution and metastasis. MITF, a key transcription factor in melanoma, promotes cell proliferation, suppresses senescence, and is associated with immune infiltration and therapy resistance. The binding activity of MITF and its regulation by signaling pathways such as AP1 and Notch impact the phenotype of tumor cells.
PIGMENT CELL & MELANOMA RESEARCH
(2022)
Article
Biochemistry & Molecular Biology
Heejin Lim, Taewoo Yang, Wongeun Lee, Sung-Gyoo Park
Summary: The study demonstrates that MDSCs are a source of MFGE8, which plays a role in tumor metastasis. TME positively regulates MFGE8 production by MDSCs through TGF-beta, suggesting MFGE8 as an important effector molecule for MDSCs to promote tumor metastasis.
Article
Oncology
Brihget Sicairos, Shorna Alam, Yuchun Du
Summary: Contrary to previous beliefs, the CDH1 gene and E-cadherin protein are not downregulated during tumor progression and metastasis. Instead, their levels are often upregulated or remain unchanged in most carcinoma cells. The upregulation of CDH1 mRNA in the early stages of tumor development may serve as a reliable biomarker for the diagnosis of certain cancers.
Article
Cell Biology
Shiyang Chen, Yajuan Zheng, Xiaojuan Ran, Hui Du, Hua Feng, Lei Yang, Yating Wen, Changdong Lin, Shihui Wang, Mengwen Huang, Zhanjun Yan, Dianqing Wu, Hongyan Wang, Gaoxiang Ge, An Zeng, Yi Arial Zeng, Jianfeng Chen
Summary: T cell contact with intestinal stem cells and transient amplifying cells plays a crucial role in regulating ISC differentiation by influencing the Wnt and Notch signaling pathways through cell-cell signaling. This interaction is essential in maintaining intestinal homeostasis and highlighting the importance of immune cells in intestinal function.
Article
Biochemistry & Molecular Biology
Lorena Lobos-Gonzalez, Lorena Orostica, Natalia Diaz-Valdivia, Victoria Rojas-Celis, America Campos, Eduardo Duran-Jara, Nicole Farfan, Lisette Leyton, Andrew F. G. Quest, Takuji Tanaka, Masahito Shimizu, Michihiro Mutoh
Summary: The co-expression of CAV1 and E-cadherin can modulate the function of melanoma cells, but under the influence of PGE2, E-cadherin is unable to suppress CAV1-enhanced tumor metastasis and tyrosine-14 phosphorylation.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Medicine, Research & Experimental
Wenbei Ma, Zhengyuan Xie, Hui Chen, Lina Zeng, Xiaohong Chen, Songfu Feng, Xiaohe Lu
Summary: High glucose levels in diabetic corneal epithelial cells lead to abnormalities in cell junctions, with decreased E-cadherin expression and increased levels of beta-catenin in the nucleus. This disruption of the beta-catenin/E-cadherin complex promotes nuclear translocation of beta-catenin and activates the transcription and expression of matrix metallopeptidase and snail, interfering with cell adhesion. Targeting the stability of the beta-catenin/E-cadherin complex may provide a potential therapeutic approach for refractory corneal ulcers in diabetic patients.
EXPERIMENTAL BIOLOGY AND MEDICINE
(2021)
Article
Medicine, Research & Experimental
Xianjun Zhu, Mu Yang, Peiquan Zhao, Shujin Li, Lin Zhang, Lulin Huang, Yi Huang, Ping Fei, Yeming Yang, Shanshan Zhang, Huijuan Xu, Ye Yuan, Xiang Zhang, Xiong Zhu, Shi Ma, Fang Hao, Periasamy Sundaresan, Weiquan Zhu, Zhenglin Yang
Summary: Familial exudative vitreoretinopathy (FEVR) is a severe retinal vascular disease associated with mutations in genes such as CTNNA1. Mutations in CTNNA1 lead to overactivation of the beta-catenin pathway, disrupting cell adherens junctions and causing FEVR. Understanding the precise regulation of beta-catenin activation is crucial for retinal vascular development and sheds new light on the pathogenesis of FEVR.
JOURNAL OF CLINICAL INVESTIGATION
(2021)
Article
Oncology
Dario Baratti, Shigeki Kusamura, Monica Niger, Federica Perrone, Massimo Milione, Laura Cattaneo, Marcello Guaglio, Valentina Bartolini, Filippo Pietrantonio, Marcello Deraco
Summary: The study assessed the prognostic impact of biological features in CRC-PM patients undergoing surgery. Right-sided primary and BRAF mutations were associated with poorer survival, while APC mutations may be linked to better survival.
ANNALS OF SURGICAL ONCOLOGY
(2021)
Article
Oncology
Caterina Peraldo-Neia, Paola Ostano, Maurizia Mello-Grand, Francesca Guana, Ilaria Gregnanin, Donatella Boschi, Simonetta Oliaro-Bosso, Agnese Chiara Pippione, Andrea Carenzo, Loris De Cecco, Stefano Cavalieri, Arianna Micali, Federica Perrone, Gianluca Averono, Paolo Bagnasacco, Riccardo Dosdegani, Laura Masini, Marco Krengli, Paolo Aluffi-Valletti, Guido Valente, Giovanna Chiorino
Summary: The study found that genes in HPV-negative OPSCCs are related to the immune system, while those in HPV-positive OPSCCs are mainly involved in glutathione derivative biosynthesis and xenobiotic metabolism. A potential prognostic biomarker, AKR1C3, was identified, and inhibition of it can enhance the effectiveness of Cisplatin.
Article
Oncology
Paolo Manca, Salvatore Corallo, Adele Busico, Sara Lonardi, Francesca Corti, Carlotta Antoniotti, Letizia Procaccio, Matteo Clavarezza, Valeria Smiroldo, Gianluca Tomasello, Roberto Murialdo, Andrea Sartore-Bianchi, Patrizia Racca, Filippo Pagani, Giovanni Randon, Antonia Martinetti, Elisa Sottotetti, Federica Palermo, Federica Perrone, Elena Tamborini, Michele Prisciandaro, Alessandra Raimondi, Maria Di Bartolomeo, Federica Morano, Filippo Pietrantonio
Summary: Analysis of ctDNA in mCRC patients revealed that the presence of RAS or PIK3CA mutations in baseline ctDNA is associated with worse PFS and OS, which can help refine the selection of patients for upfront anti-EGFR strategies.
CLINICAL CANCER RESEARCH
(2021)
Review
Biochemistry & Molecular Biology
Francesca De Santis, Giovanni Fuca, Dirk Schadendorf, Alberto Mantovani, Luca Magnani, Michael Lisanti, Stephen Pettitt, Matteo Bellone, Giannino Del Sal, Saverio Minucci, Alexander Eggermont, Paolo Bruzzi, Silvio Bicciato, Pierfranco Conte, Roberta Noberini, John Hiscott, Filippo De Braud, Michele Del Vecchio, Massimo Di Nicola
Summary: Experts at the Tenth Edition of the Annual Congress on Anticancer Innovative Therapy shared the latest knowledge and novel therapeutic approaches in fields such as immuno-oncology, epigenetics, cancer metabolism, cancer stem cells, tumor cell signaling, and the immune system. The conference also discussed possible mechanisms of resistance to these innovative therapies, particularly with respect to immune checkpoint blockers (ICB), providing a broad overview of future challenges and hopes for improving cancer treatment in the medium-short term.
CYTOKINE & GROWTH FACTOR REVIEWS
(2021)
Article
Oncology
Elisabetta Vergani, Elena Daveri, Viviana Vallacchi, Laura Bergamaschi, Luca Lalli, Chiara Castelli, Monica Rodolfo, Licia Rivoltini, Veronica Huber
Summary: The impact of extracellular vesicles (EVs) on anti-tumor immune responses is still being explored. The small size and numerous subtypes of EVs, as well as the difficulty in determining their origin, pose challenges for investigation. While the study of cancer EVs has been facilitated by the existence of tumor cell lines, understanding the phenotypes and functions of immune cell EVs in this context is more complex. The emergence of immunotherapy with immune checkpoint inhibitors has increased the need to understand the role of EVs in immune activation and response, particularly in unraveling and preventing resistance in patients.
SEMINARS IN CANCER BIOLOGY
(2022)
Article
Oncology
Laura Deborah Locati, Mara Serena Serafini, Andrea Carenzo, Silvana Canevari, Federica Perrone, Ester Orlandi, Serena Delbue, Stefano Cavalieri, Giulia Berzeri, Anna Pichiecchio, Lisa Francesca Licitra, Enrico Marchioni, Loris De Cecco
Summary: In this case report, the activity of checkpoint inhibitors (ICI) was supported in a special cancer patient population. Further investigation is needed to determine whether JCV and HPV infections (alone or together) could have a possible role as immune boosters.
FRONTIERS IN ONCOLOGY
(2022)
Article
Oncology
Chiara Colombo, Marco Fiore, Giovanni Grignani, Francesco Tolomeo, Alessandra Merlini, Elena Palassini, Paola Collini, Silvia Stacchiotti, Paolo Giovanni Casali, Federica Perrone, Luigi Mariani, Alessandro Gronchi
Summary: This study aimed to assess the behavior of primary sporadic desmoid fibromatosis (DF) managed by active surveillance (AS). The results showed that AS can effectively control the disease and spontaneous regression may occur. However, extra caution should be taken in the management of larger tumors, tumors located in extremities, and patients with certain gene mutations.
CLINICAL CANCER RESEARCH
(2022)
Article
Oncology
Federica Morano, Alessandra Raimondi, Filippo Pagani, Sara Lonardi, Lisa Salvatore, Chiara Cremolini, Sabina Murgioni, Giovanni Randon, Federica Palermo, Lorenzo Antonuzzo, Nicoletta Pella, Patrizia Racca, Michele Prisciandaro, Monica Niger, Francesca Corti, Francesca Bergamo, Alberto Zaniboni, Margherita Ratti, Michele Palazzo, Celeste Cagnazzo, Maria Alessandra Calegari, Federica Marmorino, Iolanda Capone, Elena Conca, Adele Busico, Silvia Brich, Elena Tamborini, Federica Perrone, Massimo Di Maio, Massimo Milione, Maria Di Bartolomeo, Filippo de Braud, Filippo Pietrantonio
Summary: This trial evaluated the efficacy and safety of an immune-sensitizing strategy in patients with MSS and MGMT-silenced mCRC. The results showed that a combination of temozolomide priming followed by low-dose ipilimumab and nivolumab may induce durable clinical benefit in these patients.
JOURNAL OF CLINICAL ONCOLOGY
(2022)
Article
Oncology
Monica Niger, Federico Nichetti, Andrea Casadei-Gardini, Federica Morano, Chiara Pircher, Elena Tamborini, Federica Perrone, Matteo Canale, Daniel B. Lipka, Andrea Vingiani, Luca Agnelli, Anna Dobberkau, Jennifer Huellein, Felix Korell, Christoph E. Heilig, Sara Pusceddu, Francesca Corti, Michele Droz, Paola Ulivi, Michele Prisciandaro, Maria Antista, Marta Bini, Laura Cattaneo, Massimo Milione, Hanno Glimm, Bruno C. Koehler, Giancarlo Pruneri, Daniel Huebschmann, Stefan Froehling, Vincenzo Mazzaferro, Filippo Pietrantonio, Maria Di Bartolomeo, Filippo de Braud
Summary: This study investigated the impact of O-6-methylguanine-DNA methyltransferase (MGMT) inactivation in biliary tract cancers (BTCs). The results showed that MGMT inactivation is common in BTC and is associated with poor prognosis. This provides a theoretical basis for exploring DNA-damaging agents for the treatment of MGMT-inactivated BTC.
MOLECULAR ONCOLOGY
(2022)
Article
Oncology
Jacopo Azzollini, Andrea Vingiani, Luca Agnelli, Elena Tamborini, Federica Perrone, Elena Conca, Iolanda Capone, Adele Busico, Bernard Peissel, Erica Rosina, Monika Ducceschi, Mara Mantiero, Salvatore Lopez, Francesco Raspagliesi, Monica Niger, Matteo Duca, Silvia Damian, Claudia Proto, Filippo de Braud, Giancarlo Pruneri, Siranoush Manoukian
Summary: This study evaluates the performance of a tumour-to-germline diagnostic flowchart model in identifying patients with BRCA gene mutations. The results show that this model is more effective in identifying carriers of BRCA gene mutations compared to guideline-based germline testing following genetic counselling.
FRONTIERS IN ONCOLOGY
(2022)
Article
Oncology
Monica Niger, Federico Nichetti, Andrea Casadei-Gardini, Mario Domenico Rizzato, Chiara Pircher, Marta Bini, Andrea Franza, Margherita Rimini, Valentina Burgio, Caterina Sposetti, Lorenzo Fornaro, Ilario Giovanni Rapposelli, Francesco Enrico D'Amico, Giuseppe Aprile, Caterina Vivaldi, Giovanni Luca Frassineti, Massimo Milione, Giuseppe Leoncini, Alessandro Cappetta, Enrico Vasile, Matteo Fassan, Federica Morano, Federica Perrone, Elena Tamborini, Giancarlo Pruneri, Sara Lonardi, Vincenzo Mazzaferro, Filippo Pietrantonio, Maria Di Bartolomeo, Filippo de Braud
Summary: This study investigated the impact of IDH1/2 mutations on progression-free survival, overall response rate, and disease control rate in iCCA patients treated with platinum-based chemotherapy. The results showed that IDH1/2 mutations are not associated with increased sensitivity to platinum-based chemotherapy in iCCA patients. Furthermore, the analysis of TCGA data indicated that IDH1/2 mutated CCA did not show higher HRD compared to wild-type cases.
INTERNATIONAL JOURNAL OF CANCER
(2022)
Meeting Abstract
Oncology
E. Verzoni, K. Todoerti, L. Rivoltini, V. Huber, M. Rodolfo, L. Agnelli, A. Devecchi, A. Busico, F. Perrone, G. Centonze, L. De Cecco, M. Claps, V. Guadalupi, M. Stellato, P. Giannatempo, F. G. M. De Braud, G. Procopio, P. Sepe
ANNALS OF ONCOLOGY
(2022)
Article
Endocrinology & Metabolism
Giovanni Centonze, Patrick Maisonneuve, Natalie Prinzi, Sara Pusceddu, Luca Albarello, Eleonora Pisa, Massimo Barberis, Alessandro Vanoli, Paola Spaggiari, Paola Bossi, Laura Cattaneo, Giovanna Sabella, Enrico Solcia, Stefano La Rosa, Federica Grillo, Giovanna Tagliabue, Aldo Scarpa, Mauro Papotti, Marco Volante, Alessandro Mangogna, Alessandro Del Gobbo, Stefano Ferrero, Luigi Rolli, Elisa Roca, Luisa Bercich, Mauro Benvenuti, Luca Messerini, Frediano Inzani, Giancarlo Pruneri, Adele Busico, Federica Perrone, Elena Tamborini, Alessio Pellegrinelli, Ketevani Kankava, Alfredo Berruti, Ugo Pastorino, Nicola Fazio, Fausto Sessa, Carlo Capella, Guido Rindi, Massimo Milione
Summary: This study analyzed a large series of neuroendocrine carcinomas (NECs) to validate previously identified prognostic factors and determine if additional parameters could be isolated. The most relevant predictors for prognosis were Ki-67 index, morphology, stage, and site. However, morphology was not a significant factor when Ki-67 was greater than or equal to 55%.
NEUROENDOCRINOLOGY
(2023)
Meeting Abstract
Oncology
Katia Todoerti, Pierangela Sepe, Devecchi Andrea, Adele Busico, Luca Agnelli, Federica Perrone, Chiara Gargiuli, Matteo Dugo, Loris De Cecco, Melanie Claps, Giuseppe Fotia, Valentina Guadalupi, Elena Verzoni, Giuseppe Procopio
JOURNAL OF CLINICAL ONCOLOGY
(2022)
Meeting Abstract
Oncology
Lisa F. Licitra, Mara Serena Serafini, Federico Pistore, Deborah Lenoci, Mario Airoldi, Maria Cossu Rocca, Primoz Strojan, Cvetka Grasic Kuhar, Marco C. Merlano, Nerina Denaro, Francesco Perri, Athanassios Argiris, Cristina Gurizzan, Federica Perrone, Maria Grazia Ghi, Alessandra Cassano, Giacomo Allegrini, Loris De Cecco, Paolo Bossi
JOURNAL OF CLINICAL ONCOLOGY
(2022)
Article
Cell Biology
Ke Mi, Lizhong Zeng, Yang Chen, Jingya Ning, Siyuan Zhang, Peilin Zhao, Shuanying Yang
Summary: In this study, the researchers explored the role of DHX38 in NSCLC and its underlying molecular mechanism. They found that DHX38 was overexpressed in NSCLC and patients with high DHX38 expression had poor prognosis. DHX38 promoted cell proliferation, migration, and invasion in NSCLC and activated the MAPK pathway. The researchers also identified G3BP1 as a target protein that interacted with DHX38 and showed that DHX38 regulated the expression of G3BP1. Silencing G3BP1 reversed the effects of DHX38 overexpression on tumor cell proliferation, migration, and invasion and inhibited the MAPK pathway activation.
CELLULAR SIGNALLING
(2024)
Article
Cell Biology
Tiina A. Jokela, Mark A. Dane, Rebecca L. Smith, Kaylyn L. Devlin, Sundus Shalabi, Jennifer C. Lopez, Masaru Miyano, Martha R. Stampfer, James E. Korkola, Joe W. Gray, Laura M. Heiser, Mark A. Labarge
Summary: Microenvironment signals have a significant impact on cell fate and tissue homeostasis. Understanding how different microenvironment factors regulate cellular phenotype has been challenging. In this study, a high-throughput microenvironment microarray was used to identify factors that support the proliferation and maintenance of primary human mammary luminal epithelial cells. Multiple factors that modulate luminal cell number were identified and their effects were confirmed using RNA sequencing and cell-based functional studies. Hepatocyte growth factor (HGF) was found to be robust to individual variation and played a role in expanding luminal cells. Our approach demonstrates the power of high-dimensional cell-based approaches in dissecting microenvironmental signals.
CELLULAR SIGNALLING
(2024)
Article
Cell Biology
Chao He, Yongfeng Ding, Yan Yang, Gang Che, Fei Teng, Haohao Wang, Jing Zhang, Donghui Zhou, Yanyan Chen, Zhan Zhou, Haiyong Wang, Lisong Teng
Summary: This study categorized gastric cancer patients into three stemness subtypes, each demonstrating distinct prognoses, components of tumor microenvironment (TME) infiltration, and varying sensitivity or resistance to treatment. A stemness risk model was constructed to predict treatment response and prognosis.
CELLULAR SIGNALLING
(2024)
Article
Cell Biology
Haile Zhao, Lijuan Feng, Rui Cheng, Man Wu, Xiaozhou Bai, Lifei Fan, Yaping Liu
Summary: miR-29c-3p is overexpressed in benign and malignant ovarian carcinoma and is associated with poor prognosis. Its overexpression modulates tumorigenesis in ovarian cancer cells, including epithelial-mesenchymal transition, proliferation, migration, and invasion, through the regulation of DNMT3A, TET1, and HBP1. miR-29c-3p may serve as a potential biomarker for clinical diagnosis or co-diagnosis of ovarian carcinoma.
CELLULAR SIGNALLING
(2024)
Article
Cell Biology
Haiyan Zhao, Fangfang Bi, Mengyuan Li, Yuhan Diao, Chen Zhang
Summary: This study confirmed the tumor suppressor effect of RNF180 on ovarian cancer, elucidated the mechanism of the molecule network related to RNF180 and IPO4 in ovarian cancer, and identified a new therapeutic target for ovarian cancer.
CELLULAR SIGNALLING
(2024)
Article
Cell Biology
Chu Chen, Guanhua Xu, Jiajia Chen, Chunshuai Wu, Jinlong Zhang, Jiawei Jiang, Hongxiang Hong, Zhiming Cui
Summary: This study investigated the role of transcription factor FoxO1 in facet joint osteoarthritis (FJOA) and found that FoxO1 deletion led to severe osteoarthritic changes. Transcriptome sequencing and bioinformatics analysis identified differentially expressed genes (DEGs) and potential key contributors to FJOA. Additionally, over-expression of certain genes and inhibition of others were shown to counteract the impairments caused by FoxO1 deletion in chondrocyte migration and extracellular matrix synthesis. These findings help unravel the molecular mechanisms underlying FJOA and open up promising therapeutic avenues for its treatment.
CELLULAR SIGNALLING
(2024)
Article
Cell Biology
Wen Deng, Ru Chen, Situ Xiong, Jianqiang Nie, Hailang Yang, Ming Jiang, Bing Hu, Xiaoqiang Liu, Bin Fu
Summary: This study demonstrates that circFSCN1 is upregulated in bladder cancer and associated with cancer-specific survival. CircFSCN1 promotes tumor progression and epithelial-mesenchymal transition in bladder cancer through enhancing MDM2-mediated silencing of p53 by sponging miR-145-5p.
CELLULAR SIGNALLING
(2024)
Article
Cell Biology
Jun Wu, Weibin Hu, Wenhui Yang, Yihao Long, Kaizhao Chen, Fugui Li, Xiaodong Ma, Xun Li
Summary: Cholesterol biosynthesis and metabolism play critical roles in tumor development and microenvironmental conditions. Squalene Epoxidase (SQLE), the second rate-limiting enzyme in cholesterol synthesis, is found to be uniquely expressed in various cancers, and its expression level is closely associated with tumor mutation burden and microsatellite instability. SQLE expression is negatively correlated with immune cell infiltration. Inhibition of SQLE alters the immune response in the tumor microenvironment. Furthermore, protein metabolism and translation are identified as main binding factors with SQLE.
CELLULAR SIGNALLING
(2024)
Article
Cell Biology
Zhihong Zhang, Mingyue Li, Yi Tai, Yue Xing, Hongxiang Zuo, Xuejun Jin, Juan Ma
Summary: ZNF70 plays an important role in colitis-associated colorectal cancer (CAC) by regulating macrophages IL-1 beta secretion to promote HCT116 proliferation. It may serve as a promising target for treating CAC.
CELLULAR SIGNALLING
(2024)
Article
Cell Biology
Zenghong Wu, Gangping Li, Weijun Wang, Kun Zhang, Mengke Fan, Yu Jin, Rong Lin
Summary: This study comprehensively explored the role of immune checkpoints and tumor microenvironment in gastric cancer patients based on genomic data. It constructed an ICIs signature and ICI score to evaluate patient prognosis and heterogeneity.
CELLULAR SIGNALLING
(2024)
Article
Cell Biology
Yantong Wan, Jieshu Zhou, Panpan Zhang, Xuemei Lin, Hao Li
Summary: This study found that Rac1 plays a role in astrocyte activation and attenuates chronic inflammatory pain by blocking the phosphorylation of NLRP3 inflammasome and NF-kappa B.
CELLULAR SIGNALLING
(2024)
Article
Cell Biology
Zhen Wang, Diankun She, Lei Liu, Xianming Hua, Hao Zhu, Lingfeng Yu, Han Wang, Yan Zhu, Gentao Fan, Yicun Wang, Meng Xu, Guangxin Zhou
Summary: Circular RNAs (circRNAs) are non-coding RNAs that play a role in the regulation of various cancers, including osteosarcoma (OS). This study identified circSATB2 as a highly expressed circRNA in OS tissues and cell lines, and demonstrated its involvement in promoting OS proliferation and migration. Mechanistically, circSATB2 was found to regulate the progression of OS by sponging miR-661 and FUS to regulate ZNFX1 mRNA. These findings suggest that circSATB2 could serve as a prognostic marker and therapeutic target for osteosarcoma.
CELLULAR SIGNALLING
(2024)
Article
Cell Biology
Kenichi Ogata, Masafumi Moriyama, Tatsuya Kawado, Hiroki Yoshioka, Aiko Yano, Mayu Matsumura-Kawashima, Seiji Nakamura, Shintaro Kawano
Summary: This study found that extracellular vesicles released by induced pluripotent stem cells can reduce inflammatory cell infiltration, increase saliva volume, and decrease the production of antibodies associated with Sjogren's syndrome in a mouse model. The let-7 family in these vesicles may suppress the expression of TLR4 and NF-kappa B, which leads to the inhibition of pro-inflammatory cytokine production through the MAPK pathway.
CELLULAR SIGNALLING
(2024)
Article
Cell Biology
Mikayla R. Erdelsky, Sarah A. Groves, Charmi Shah, Samantha B. Delios, M. Bibiana Umana, Donald H. Maurice
Summary: Recent evidence suggests that cAMP signaling within the primary cilium plays a crucial role in promoting adipogenic differentiation of 3T3-L1 preadipocytes. In this study, the researchers identified the specific cAMP phosphodiesterases expressed by these cells and found that inhibition of PDE4 promotes FFAR4-mediated adipogenesis. This work could potentially lead to the discovery of more targeted therapeutic approaches for controlling adipogenesis and differentiation of other stem cells.
CELLULAR SIGNALLING
(2024)
Article
Cell Biology
Chun-Hui Liu, Jun-Jie Zhang, Qian-Jin Zhang, Yang Dong, Zhen-Duo Shi, Si-Hao Hong, Hou-Guang He, Wei Wu, Cong-Hui Han, Lin Hao
Summary: Bladder cancer, the most common malignant tumor in the urinary system, is associated with significantly up-regulated expression of P3H4, which is regulated by METTL3 and plays a crucial role in the proliferation, metastasis, and EMT progression of bladder cancer. Targeting this METTL3-P3H4 pathway may serve as a potential therapeutic strategy for bladder cancer.
CELLULAR SIGNALLING
(2024)